Alloplex Biotherapeutics LLC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersWinchester, MA
US patents4
SAM.gov UEIGSVXCLTBJTG7
CAGE code7TBH9
Incorporated inDE
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
4 US patents granted 2020–2025, 3 of them in the five years to SEP 2025.
Pharmaceuticals 4
- Allogeneic tumor cell vaccineUS 12,403,186 · granted SEP 2, 2025
- Allogeneic tumor cell vaccineUS 11,185,586 · granted NOV 30, 2021
- Allogeneic tumor cell vaccineUS 11,058,752 · granted JUL 13, 2021
- Compositions and methods for in vitro activation and expansion of serial killer T cell populations and passive immunization of a cancer patient with tumor cell killing cellsUS 10,731,128 · granted AUG 4, 2020
Granted to Alloplex Biotherapeutics, Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Alloplex Biotherapeutics LLC | Winchester | MA | — | LIKELY ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.